论文部分内容阅读
目的探讨阿奇霉素治疗小儿呼吸道感染的临床疗效。方法选取2009年3月-2012年2月期间连云港市中医院收治的100例小儿呼吸道感染患儿,治疗组每天静脉注射一次乳糖酸阿奇霉素注射液。对照组每天静脉注射一次阿莫西林钠克拉维酸钾注射液,一个疗程为6d。密切观察两组患儿的临床疗效。结果注射用乳糖酸阿奇霉素组治疗小儿呼吸道感染的治愈率(98.0%)明显高于对照组(88.0%),与此同时,注射用乳糖酸阿奇霉素组的不良反应发生率(5.5%)明显低于对照组(12.5%)。结论注射用乳糖酸阿奇霉素对于治疗小儿呼吸道感染具有较好的疗效和安全性,值得在临床上推广使用。
Objective To investigate the clinical efficacy of azithromycin in the treatment of pediatric respiratory infections. Methods From March 2009 to February 2012, 100 cases of children with respiratory tract infection were treated in Lianyungang Hospital of Traditional Chinese Medicine. The treatment group received daily intravenous injection of azithromycin lactobionate. Control group intravenous injection of amoxicillin sodium clavulanate potassium injection, a course of 6d. Close observation of the clinical efficacy of two groups of children. Results The cure rate (98.0%) was significantly higher in the infants receiving azithromycin lactobionate than in the control group (88.0%), while the rate of adverse reactions (5.5%) in the azithromycin group was significantly lower than that of the control group Control group (12.5%). Conclusion Injection of azithromycin lactobionate for the treatment of children with respiratory tract infection has good efficacy and safety, it is worth in the clinical promotion.